Glycobond logo

Glycobond

The company’s first product is an assay for HCC diagnosis, HepaCheC®

1 employees · est. 2011 · Linkoping, Sweden

VS
Zhiyu Technology logo

Zhiyu Technology

Redefining the Future of AI-Assisted Diagnostics and Telemedicine Through Advanced Medical Imaging Analysis for Liver and Brain Health

Side-by-Side Comparison

Glycobond Zhiyu Technology
Founded
2011 Not tracked yet
Headquarters
Linkoping, Sweden Not tracked yet
Employees
1 Not tracked yet
Industry
Biotechnology, Health Care Health Care
Funding Stage
Grant Seed
Total Funding
$50.00K $10.00M
Funding Rounds
3 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Medical Diagnostics, Cancer Diagnosis, Liver Diseases, Carbohydrate-binding Peptides, Recombinant Technology, CE-marked Assay, HCC Diagnosis, Liver Cancer Monitoring AI-assisted Diagnostics, Telemedicine, Medical Imaging Analysis, Liver Health, Brain Health, MR Medical Imaging, AI Software Products, Stroke Analysis, Parkinson's Diagnosis, Cirrhosis Evaluation, Liver Tumor Analysis, Surgical Planning, Innovative Medical Technology, Healthcare Innovation, Data-driven Healthcare
Website
glycobond.com zyheal.com
Glycobond logo

About Glycobond

Glycobond is a biotechnology startup based in Sweden that utilizes recombinant technology to produce carbohydrate-binding peptides for the diagnosis and monitoring of liver diseases and cancer. Their flagship product, HepaCheC®, is a CE-marked assay designed to aid in the diagnosis of primary liver...

Zhiyu Technology logo

About Zhiyu Technology

Zhiyu Technology is a pioneer in the field of medical imaging technology with a mission to redefine the future of AI-assisted diagnostics and telemedicine. Specializing in intelligent analysis services for MR medical imaging, Zhiyu is dedicated to advancing liver and brain medical AI. The company se...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Glycobond and Zhiyu Technology — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Glycobond and Zhiyu Technology — by email.

Frequently Asked Questions

Glycobond — The company’s first product is an assay for HCC diagnosis, HepaCheC®. Zhiyu Technology — Redefining the Future of AI-Assisted Diagnostics and Telemedicine Through Advanced Medical Imaging Analysis for Liver and Brain Health. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Glycobond has raised $50.00K while Zhiyu Technology has raised $10.00M.
Glycobond and Zhiyu Technology operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Glycobond with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy